Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

The tumor shrinkage effect of gemcitabine is considered to be limited in cases of advanced gallbladder cancer, and there are few reports of complete response to gemcitabine therapy in patients with this cancer. Therefore, the treatment continuation strategy in these patients, after a complete respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Suyama, Koichi, Ikeda, Masafumi, Suzuki, Eiichiro, Kojima, Motohiro, Mitsunaga, Shuichi, Shimizu, Satoshi, Ohno, Izumi, Takahashi, Hideaki, Okuyama, Hiroyuki, Kuwahara, Akiko, Okusaka, Takuji, Furuse, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: October, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843915/
https://www.ncbi.nlm.nih.gov/pubmed/24348389
http://dx.doi.org/10.1159/000356080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843915/
https://www.ncbi.nlm.nih.gov/pubmed/24348389
http://dx.doi.org/10.1159/000356080

Ejemplares similares